glp-1 liver fibrosis 🔬 Big news for anyone managing fatty disease — this one's worth knowing about! A study just published this week in one of the world's top medical journals asked a question Repurposing GLP-1 Receptor Agonists: A

With fewer barriers, this oral GLP-1 approach becomes a more practical option in these cases

Know what youre getting when choosing a GLP-1 Compounded GLP-1s are often promoted as personalized medicine, but they come with risks that should be navigated carefully

They are meant to support a healthy diet and exercise regime for long-term, sustainable weight loss

Khajavi N, Biebermann H, Tschp M, DiMarchi R (2017) Treatment of diabetes and obesity by rationally designed peptide agonists functioning at multiple metabolic receptors

The bigger outcome is that this study needs to be conducted on a larger scale

The market has witnessed explosive growth, particularly with the emergence of dual- and tri-agonist formulations and extended applications in obesity, metabolic syndrome, and even addiction and Alzheimers disease